Results 101 to 110 of about 12,566 (189)

Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants. [PDF]

Hum Genet, 2022
Kehrer-Sawatzki H, Cooper DN.
europepmc   +1 more source

Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study. [PDF]

Cureus
Grau L, Zempsky WA, Martin S, Larkin K, Buono FD.   +4 more
europepmc   +1 more source

Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth. [PDF]

PLoS Genet, 2021
Well L, Döbel K, Kluwe L, Bannas P, Farschtschi S, Adam G, Mautner VF, Salamon J.   +7 more
europepmc   +1 more source

Penile squamous cell carcinoma in neurofibromatosis type 1 (NF1): RAS-pathway mechanisms and management - A case report. [PDF]

Urol Case Rep
Javanmard B, Samenezhad S, Rafighi D, Yaghoubpour L, Dehghan N.   +4 more
europepmc   +1 more source

Current states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1). [PDF]

Acta Neuropathol Commun
Aghoghovwia BE, Shen CE, Bano S, Shyamala N, Echeandia Marrero A, Irshad K, Sharafaldin S, Brossier NM, Pan Y.   +8 more
europepmc   +1 more source

Correction: Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1). [PDF]

PLoS One, 2021
PLOS ONE Staff.
europepmc   +1 more source

'Alone on our NF1 island': a patient-led mixed-method survey study to understand the care pathway for neurofibromatosis type 1 (NF1) patients in the UK. [PDF]

BMJ Open Qual
Ju S, Cowley L, Jain I, Martin V, Day E, Smith R, Morgan T.   +6 more
europepmc   +1 more source

Occurrence of Multiple Psychiatric Comorbidities in a Child with Neurofibromatosis Type 1 (NF1): A Case Report. [PDF]

Cureus
Abedi AS, Asad N, Patel H, Abedi MS, Ali R.   +4 more
europepmc   +1 more source

Clinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARC. [PDF]

ESMO Open
Cuvelier C, Brahmi M, Sobhani I, Verret B, Grancher A, Penel N, Toulmonde M, Lahlou W, Dupuis H, Calavas L, Muller M, Watson S, Bruyat D, Poumeaud F, Chaigneau L, Manfredi S, Lecomte T, Bertucci F, Ghiringhelli F, Pracht M, Mourthadhoi F, Monceau-Baroux L, Helyon M, Kurtz JE, Roquin G, Regenet N, Vinches M, Tougeron D, Wolkenstein P, Blay JY, Bouche O, Hautefeuille V.   +31 more
europepmc   +1 more source

A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib. [PDF]

Cancers (Basel)
Curlee MS, Toledo-Tamula MA, Baker M, Wikstrom D, Harrison C, Rhodes A, Fagan M, Tibery C, Wolters PL, Widemann BC, Gross AM, Martin S.   +11 more
europepmc   +1 more source